封面
市场调查报告书
商品编码
1741519

高温癌症治疗市场按治疗类型、应用、最终用户和地区划分

Hyperthermia Cancer Treatment Market, By Treatment Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年高温癌症治疗市场规模估计为 2.105 亿美元,预计到 2032 年将达到 3.186 亿美元,2025 年至 2032 年的复合年增长率为 6.1%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 2.105亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 6.10% 2032年价值预测 3.186亿美元

高温癌症治疗是一种利用热量治疗癌细胞的新型治疗方法。高温疗法可以透过外部热源或直接将热量引导至肿瘤部位来提高癌细胞的温度。高温疗法可与其他癌症治疗方法(例如化疗和放射线治疗)合併使用,以增强其疗效。

高温治疗将恶性细胞置于高温下,目的是杀死癌细胞,增强放射治疗的有效性,并增加化疗药物的吸收。高温治疗是一种非侵入性治疗方法,由于其与传统治疗方法相比,具有改善患者预后并最大程度减少副作用的潜力,在肿瘤学领域正日益受到重视。

市场动态:

预计全球高温癌症治疗市场在预测期内将显着成长。推动这一成长的市场动态包括多种因素,例如全球癌症盛行率上升、创新癌症治疗方法的采用率不断提高以及技术进步。

全球癌症患者数量的成长是高温癌症治疗市场的主要驱动力之一。根据国际癌症研究机构2021年5月发布的数据,2020年预计新增癌症病例1,930万例。预计癌症发生率的上升将刺激对包括高温疗法在内的有效治疗方案的需求。

此外,热疗设备的技术进步预计将推动市场成长。局部热疗和全身热疗等先进加热技术的发展,改善了治疗效果,拓展了热疗的应用范围。此外,热疗设备与显像模式的融合,实现了即时温度监测和癌细胞的精准靶向,进一步提高了治疗效果。

儘管市场潜力巨大,但某些因素可能会抑制其成长。例如,医护人员和病患对高温治疗的认知度较低、治疗费用高昂、以及报销困难等,都是阻碍市场扩张的一些因素。然而,提高认知度、优惠的报销政策以及持续的研发活动有望克服这些挑战。

本研究的主要特点

  • 本报告对全球高温癌症治疗市场进行了详细分析,并提供了预测期 2025-2032 的市场规模和复合年增长率(CAGR,%),以 2024 年为基准年。
  • 它还强调了各个领域的潜在商机,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球高温癌症治疗市场的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
  • 全球癌症发生率正在上升
  • 热疗系统高成本
  • 奈米粒子介导的热疗越来越受欢迎
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章 高温癌症治疗市场-冠状病毒 (COVID-19) 大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年高温癌症治疗市场(依治疗类型)

  • 局部高温
  • 局部高温
  • 全身热疗

6. 2020 年至 2032 年高温癌症治疗市场(依应用)

  • 摄护腺癌
  • 乳癌
  • 子宫颈癌
  • 皮肤癌
  • 其他癌症

7. 2020 年至 2032 年热疗癌症治疗市场(依最终使用者划分)

  • 医院
  • 诊所
  • 专业中心
  • 其他(学术研究机构)

8. 2020 年至 2032 年热疗癌症治疗市场(按地区)

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第九章 竞争态势

  • MagForce AG
  • Andromedic Srl
  • Celsius42 GmbH
  • Oncotherm Kft
  • Pyrexar Medical
  • YAMAMOTO VINITA CO.,LTD
  • Nanoprobes
  • Alba Hyperthermia System
  • Novavida
  • Sensius

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6415

Hyperthermia Cancer Treatment Market is estimated to be valued at USD 210.5 Mn in 2025 and is expected to reach USD 318.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 210.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.10% 2032 Value Projection: USD 318.6 Mn

Hyperthermia cancer treatment is a novel therapeutic approach that utilizes heat to treat cancer cells. It involves raising the temperature of cancerous cells, either from external sources or by directing heat specifically to the tumor site. Hyperthermia can be used in conjunction with other cancer treatments like chemotherapy and radiation therapy to improve their efficacy.

By subjecting malignant cells to higher temperatures, hyperthermia treatment aims to kill cancer cells, enhance the effectiveness of radiation therapy, and increase the uptake of chemotherapeutic agents. It is a non-invasive method that is gaining momentum in the field of oncology due to its potential to improve patient outcomes and minimize side effects compared to traditional treatments.

Market Dynamics:

The global hyperthermia cancer treatment market is expected to experience significant growth during the forecast period. The market dynamics driving this growth include various factors such as the rising prevalence of cancer worldwide, increasing adoption of innovative cancer treatment methods, and advancements in technology.

Rising cases of cancer globally is one of the key drivers of the Hyperthermia cancer treatment market. According to the data published by the International Agency for Research on Cancer in May 2021, an estimated 19.3 million new cancer cases occurred in 2020. This growing incidence of cancer is expected to fuel demand for effective treatment options, including hyperthermia therapy.

Moreover, technological advancements in hyperthermia treatment devices are expected to propel market growth. The development of advanced heating techniques, such as regional and whole-body hyperthermia, has improved treatment outcomes and expanded the applicability of hyperthermia therapy. Additionally, the integration of hyperthermia devices with imaging modalities allows for real-time temperature monitoring and precise targeting of tumor cells, further enhancing treatment efficacy.

While the market holds immense potential, certain factors may restrain its growth. Limited awareness about hyperthermia treatment among healthcare professionals and patients, high treatment costs, and reimbursement challenges are some of the obstacles that may hinder market expansion. However, efforts to increase awareness, favorable reimbursement policies, and ongoing research and development activities are expected to overcome these challenges.

Key Features of the Study:

  • This report provides in-depth analysis of the global hyperthermia cancer treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR, %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Key companies covered as a part of this study include MagForce AG, Andromedic S.r.l., Celsius42 GmbH, Oncotherm Kft, Pyrexar Medical, YAMAMOTO VINITA CO.,LTD, Nanoprobes, Alba Hyperthermia System, Novavida, and Sensius.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgradation, market expansion, and marketing tactics.
  • The global hyperthermia cancer treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hyperthermia cancer treatment market

Hyperthermia Cancer Treatment Market Detailed Segmentation:

  • By Treatment Type:
    • Local Hyperthermia
    • Regional Hyperthermia
    • Whole Body Hyperthermia
  • By Application:
    • Prostate Cancer
    • Breast Cancer
    • Cervical Cancer
    • Skin Cancer
    • Other Cancers
  • By End User:
    • Hospitals
    • Clinic
    • Specialty Centres
    • Others (Academic and Research Institute)
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • MagForce AG
    • Andromedic S.r.l.
    • Celsius42 GmbH
    • Oncotherm Kft
    • Pyrexar Medical
    • YAMAMOTO VINITA CO.,LTD
    • Nanoprobes
    • Alba Hyperthermia System
    • Novavida
    • Sensius

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Hyperthermia Cancer Treatment Market, By Treatment Type
    • Global Hyperthermia Cancer Treatment Market, By Application
    • Global Hyperthermia Cancer Treatment Market, By End User
    • Global Hyperthermia Cancer Treatment Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of cancer worldwide
    • Restraints
  • High costs of hyperthermia systems
    • Opportunities
  • Growing popularity of nanoparticle-mediated hyperthermia
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Hyperthermia Cancer Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Hyperthermia Cancer Treatment Market , By Treatment Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Local Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Regional Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Whole Body Hyperthermia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Hyperthermia Cancer Treatment Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Breast Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cervical Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Skin Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Other Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Hyperthermia Cancer Treatment Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Clinic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Specialty Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (Academic and Research Institute)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Hyperthermia Cancer Treatment Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • MagForce AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Andromedic S.r.l.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celsius42 GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Oncotherm Kft
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pyrexar Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • YAMAMOTO VINITA CO.,LTD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nanoprobes
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alba Hyperthermia System
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novavida
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sensius
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us